clinical science /aiml/ en AIML and CCCure use machine learning to improve outcomes for those with IBD /aiml/news/list/2025/09/01/aiml-and-cccure-use-machine-learning-to-improve-outcomes-for-those-with-ibd <p><span><span><span>Inflammatory bowel disease (IBD) is a chronic condition that causes inflammation of the gastrointestinal tract, leading to symptoms such as abdominal pain, fatigue, and impaired digestion.&nbsp;</span></span></span><span><span><span>IBD affects more than 6.8 million people worldwide. In Australia, over 180,000 people are currently living with IBD, including both Crohn’s disease and ulcerative colitis, which often require long-term and complex medical management. With rates continuing to rise globally, <a href="https://c-c-cure.org/about/">IBD is projected to affect around 300,000 Australians by 2030.</a></span></span></span></p> September 01 2025 Miguel Balbin /aiml/news/list/2025/09/01/aiml-and-cccure-use-machine-learning-to-improve-outcomes-for-those-with-ibd